The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovitch, S. B.
Right arrow Articles by Unanue, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovitch, S. B.
Right arrow Articles by Unanue, E. R.
The Journal of Immunology, 2003, 171: 2183-2186.
Copyright © 2003 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing 1

Scott B. Lovitch, Shirley J. Petzold and Emil R. Unanue2

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110

We quantitated the amounts of peptides from hen egg-white lysozyme presented by I-Ak molecules in APC lines. The large chemical gradient of presentation of the four hen egg-white lysozyme epitopes observed in cell lines expressing HLA-DM or H-2DM (referred to in this study as DM) was significantly diminished in the T2.Ak line lacking DM. Differences in levels of presentation between wild-type and DM-deficient APC were observed for all four epitopes, but differences were most evident for the highest affinity epitope. As a result of these quantitative differences in display, presentation of all four epitopes to T cells was impaired in the line lacking DM. The binding affinity of the pool of naturally processed peptides from DM-expressing lines was higher than that from the DM-deficient line. Thus, using a direct biochemical approach in APC, we demonstrate that DM influences the selection of peptides bound to MHC class II by favoring high affinity peptides.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. M. Weaver, C. A. Lazarski, K. A. Richards, F. A. Chaves, S. A. Jenks, P. R. Menges, and A. J. Sant
Immunodominance of CD4 T Cells to Foreign Antigens Is Peptide Intrinsic and Independent of Molecular Context: Implications for Vaccine Design
J. Immunol., September 1, 2008; 181(5): 3039 - 3048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Menges, S. A. Jenks, E. K. Bikoff, D. R. Friedmann, Z. A. G. Knowlden, and A. J. Sant
An MHC Class II Restriction Bias in CD4 T Cell Responses toward I-A Is Altered to I-E in DM-Deficient Mice
J. Immunol., February 1, 2008; 180(3): 1619 - 1633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Grotenbreg, M. J. Nicholson, K. D. Fowler, K. Wilbuer, L. Octavio, M. Yang, A. K. Chakraborty, H. L. Ploegh, and K. W. Wucherpfennig
Empty Class II Major Histocompatibility Complex Created by Peptide Photolysis Establishes the Role of DM in Peptide Association
J. Biol. Chem., July 20, 2007; 282(29): 21425 - 21436.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
R. Soo, J Wu, A Aggarwal, Q Tao, W Hsieh, T Putti, K. Tan, W. Soon, Y. Lai, B Mow, et al.
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression
Ann. Onc., November 1, 2006; 17(11): 1625 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ireland, J. Herzog, and E. R. Unanue
Cutting Edge: Unique T Cells That Recognize Citrullinated Peptides Are a Feature of Protein Immunization
J. Immunol., August 1, 2006; 177(3): 1421 - 1425.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. A. Lazarski, F. A. Chaves, and A. J. Sant
The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability
J. Exp. Med., May 15, 2006; 203(5): 1319 - 1328.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Nicholson, B. Moradi, N. P. Seth, X. Xing, G. D. Cuny, R. L. Stein, and K. W. Wucherpfennig
Small Molecules That Enhance the Catalytic Efficiency of HLA-DM
J. Immunol., April 1, 2006; 176(7): 4208 - 4220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Honey, K. Forbush, P. E. Jensen, and A. Y. Rudensky
Effect of Decreasing the Affinity of the Class II-Associated Invariant Chain Peptide on the MHC Class II Peptide Repertoire in the Presence or Absence of H-2M1
J. Immunol., April 1, 2004; 172(7): 4142 - 4150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. W. Anderson and J. Gorski
Cutting Edge: TCR Contacts as Anchors: Effects on Affinity and HLA-DM Stability
J. Immunol., December 1, 2003; 171(11): 5683 - 5687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.